Skip to main content

Table 1 Sensitivity and specificity of OraQuick® test

From: Field comparison of OraQuick® ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia

Compared to HIV infected1, N = 4,391

Sensitivity (95% CI)

98.7% (97.5%–99.4%)

Specificity (95% CI)

99.8% (99.6%–99.9%)

Positive Predictive Value (95%CI)

99.1% (98.1%–99.7%)

Negative Predictive Value (95%CI)

99.8% (99.5%–99.9%)

  1. 1HIV infected as defined by both a positive Determine® and Uni-GoldTM test result and/or self reported positive status prior to testing with a positive Determine® or OraQuick® test result.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us